Literature DB >> 7086666

General derivation of the equation for time to reach a certain fraction of steady state.

D Perrier, M Gibaldi.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7086666     DOI： 10.1002/jps.2600710432

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  27 in total

Review 1.  Evaluation of methods for estimating time to steady state with examples from phase 1 studies.

Authors:  Lata Maganti; Deborah L Panebianco; Andrea L Maes
Journal:  AAPS J       Date:  2008-02-28       Impact factor: 4.009

2.  Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers.

Authors:  Stefan Farese; Emilie Stauffer; Robert Kalicki; Tatjana Hildebrandt; Brigitte M Frey; Felix J Frey; Dominik E Uehlinger; Andreas Pasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

3.  Simple approximate formulas for calculating the time to clear drug and the time to accumulate drug when the plasma disposition curve of the drug is multiexponential.

Authors:  D A Noe
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

4.  Accumulation profiles during quasi-uniform multiple dosing regimens.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

5.  A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.

Authors:  Nehal Mohamed; Michelle Clagett; Juan Li; Steven Jones; Steven Pincus; Giovanni D'Alia; Linda Nardone; Michael Babin; George Spitalny; Leslie Casey
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Influence of fluid therapy on gentamicin pharmacokinetics in colic horses.

Authors:  M R van der Harst; S Bull; C M Laffont; W R Klein
Journal:  Vet Res Commun       Date:  2005-02       Impact factor: 2.459

7.  A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects.

Authors:  Randy Dockens; Jun-Sheng Wang; Lorna Castaneda; Oleksandr Sverdlov; Shu-Pang Huang; Randy Slemmon; Huidong Gu; Oi Wong; Hewei Li; Robert M Berman; Christina Smith; Charles F Albright; Gary Tong
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 6.447

8.  PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.

Authors:  Jose Ramon; Vivian Saez; Reynier Baez; Raymersy Aldana; Eugenio Hardy
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

9.  Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

Authors:  Charles Frost; Sunil Nepal; Jessie Wang; Alan Schuster; Wonkyung Byon; Rebecca A Boyd; Zhigang Yu; Andrew Shenker; Yu Chen Barrett; Rogelio Mosqueda-Garcia; Frank Lacreta
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

10.  Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.

Authors:  Jason A Campagna; Kevin Pojasek; David Grayzel; John Randle; Douglas E Raines
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.